BioCentury
ARTICLE | Clinical News

Azilva azilsartan regulatory update

January 23, 2012 8:00 AM UTC

Takeda said the Japanese Ministry of Health, Labor and Welfare (MHLW) approved an NDA for 20 and 40 mg Azilva azilsartan to treat hypertension. Azilsartan is an angiotensin II type 1 (AT1) receptor (...